Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. filings document operating results, governance matters and material events for a public ethical food company built around pasture-raised eggs and related food products. Form 8-K reports furnish earnings releases, Regulation FD updates, product portfolio actions and exit or disposal activity tied to butter offerings.
Proxy and stockholder-meeting disclosures cover director elections, board structure, executive compensation advisory votes, governance policies and shareholder voting results. Other current reports document board appointments, board leadership transitions, committee service, indemnification arrangements and related corporate-governance matters for the Nasdaq-listed Delaware public benefit corporation.
Vital Farms, Inc. (VITL) filed a Form 4 reporting a routine share purchase by a senior executive. The company’s SVP of Strategy acquired 401 shares of common stock on 11/17/2025 at a price of $26.13 per share under Vital Farms’ 2020 Employee Stock Purchase Plan. After this transaction, the executive beneficially owns 46,180 shares of Vital Farms common stock held directly.
The filing notes that the purchase was made through the employee stock purchase plan at 85% of the common stock’s closing price on the purchase date and was exempt under Rule 16b-3(d) and Rule 16b-3(c). This is an administrative disclosure of insider ownership and does not describe any change to the company’s operations or strategy.
Vital Farms (VITL) — insider stock transactions disclosed. A director, executive chairperson, and 10% owner reported open‑market sales made under a Rule 10b5‑1 trading plan adopted on March 14, 2025.
On 11/03/2025, the Reporting Person sold 21,408 shares at a weighted average price of $31.85, with individual trades ranging from $31.28 to $32.27, and 3,592 shares at a weighted average price of $32.35, with trades from $32.28 to $32.54. On 11/04/2025, 5,000 shares were sold at a weighted average price of $37.78, with trades from $37.01 to $38.00.
Following these transactions, the Reporting Person beneficially owned 6,417,070 shares directly. In addition, 716,000 shares are reported indirectly by a former spouse; per the disclosure, the Reporting Person has sole voting control over these shares and no pecuniary interest.
Vital Farms (VITL) reported strong Q3 fiscal 2025 results. Net revenue rose to $198.9 million from $145.0 million a year ago, driven primarily by eggs and egg-related products at $192.6 million. Gross profit increased to $75.0 million, and net income reached $16.4 million versus $7.4 million. Diluted EPS was $0.36 compared with $0.16.
For the first 39 weeks of fiscal 2025, net revenue was $545.9 million versus $440.3 million, with net income of $50.0 million versus $42.8 million. Customer concentration remained notable, with Customer A representing 24% of Q3 net revenue and 22% year-to-date. Cash and cash equivalents were $93.8 million as of September 28, 2025, alongside $51.3 million of available-for-sale U.S. Treasury Bills.
Operating cash flow was $27.9 million year-to-date, while capital expenditures totaled $44.0 million, lifting property, plant and equipment, net to $121.1 million. The company reported no borrowings on its $60.0 million JPMorgan revolving credit facility. A July 2025 tax law change reduced current tax expense, largely offset by higher deferred tax expense, with no material net effect on the quarter’s effective tax rate.
Vital Farms furnished an 8-K announcing its financial results for the fiscal quarter ended September 28, 2025. The company shared the results via a press release attached to the filing.
The press release is included as Exhibit 99.1 and is incorporated by reference. The information in this report, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.
Vital Farms director and CEO Russell Diez-Canseco reported two sales of company common stock on 10/08/2025 under a Rule 10b5-1 trading plan. The filings show 5,263 shares sold at a weighted average price of $44.11 and 4,404 shares sold at a weighted average price of $44.72, a total of 9,667 shares disposed. After the transactions the reporting person beneficially owned 670,513 shares following the first sale and 666,109 shares following the second sale, as reported. The Form 4 states the 10b5-1 plan was adopted on 05/12/2025 and that the sales occurred in multiple transactions within the disclosed price ranges.
Matthew Ohayer, Executive Chairperson, Director and 10% owner of Vital Farms, Inc. (VITL), reported multiple open-market sales of common stock on 10/01/2025 completed under a Rule 10b5-1 trading plan adopted on March 14, 2025. The filing shows three sales: 600 shares at $38.17, 23,536 shares at a weighted average of $39.98, and 10,864 shares at a weighted average of $40.63, for a total of 35,000 shares sold. Following these transactions, the reporting person’s direct beneficial ownership is reported as 6,447,070 shares. The filing also discloses 716,000 shares held by a former spouse over which the reporting person has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Reena Chauhan Van Hoven, Chief People Officer of Vital Farms, Inc. (VITL), reported a routine share withholding transaction on 09/16/2025. The Form 4 shows 344 shares of Vital Farms common stock were disposed of under code F(1) at an indicated price of $47.05 per share, with the filer noting the shares were withheld to satisfy a withholding tax obligation. After this transaction the reporting person beneficially owned 10,765 shares, held directly.
The form is signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025. No derivative securities or other transactions are reported on this Form 4.
Reena Chauhan Van Hoven, Chief People Officer of Vital Farms, Inc. (VITL), reported a routine share withholding transaction on 09/16/2025. The Form 4 shows 344 shares of Vital Farms common stock were disposed of under code F(1) at an indicated price of $47.05 per share, with the filer noting the shares were withheld to satisfy a withholding tax obligation. After this transaction the reporting person beneficially owned 10,765 shares, held directly.
The form is signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025. No derivative securities or other transactions are reported on this Form 4.
Vital Farms insider Matthew Ohayer reported a sale of Common Stock on 09/04/2025. The filing shows 100,000 shares were sold at a weighted-average price of $50.96, with individual trade prices ranging from $50.75 to $51.21. After the reported disposition the filing shows Mr. Ohayer beneficially owns 6,482,070 shares directly and an additional 716,000 shares indirectly (held by his former spouse), over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an undertaking to provide trade-by-trade price details on request.
Vital Farms, Inc. (VITL) filing: insider sale notice. The document is a Form 144 reporting a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $5,096,010.00. The shares were originally acquired as founder stock on 01/06/2015 and paid in cash. The filer previously sold a total of 310,000 shares across multiple dates in the prior three months, generating gross proceeds shown per sale. The filing states the seller represents no undisclosed material adverse information about the issuer.
Joseph Michael Holland, identified as Chief Supply Chain Officer of Vital Farms, Inc. (VITL), reported a withholding-related disposal of company stock on 09/02/2025. The Form 4 shows 412 shares were disposed under code F(1) to satisfy withholding tax obligations at a reported price of $51.90 per share. After the transaction, the filing reports 11,451 shares beneficially owned directly by the reporting person. The form was signed by an attorney-in-fact on 09/04/2025. No derivative transactions or other securities classes are disclosed in this filing.